Can benzodiazepines cause cognitive deficits in an 18-year-old?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Benzodiazepines Cause Cognitive Deficits in 18-Year-Olds

Yes, benzodiazepines can cause cognitive deficits in 18-year-olds, with evidence showing impairments in multiple cognitive domains including memory, attention, and processing speed. 1, 2

Cognitive Effects of Benzodiazepines in Young Adults

  • Benzodiazepines are associated with cognitive impairment across multiple domains, including visuospatial ability, speed of processing, and verbal learning 1
  • Young adults (18-24 years) who use benzodiazepines show profound changes in cognitive function, particularly with high-dose or long-term use 2
  • These cognitive effects may persist even after discontinuation of the medication, with patients not returning to levels of functioning that match benzodiazepine-free controls 1

Specific Cognitive Deficits

  • Multifocal cognitive dysfunction has been documented in high-dose benzodiazepine users, affecting:
    • Verbal memory
    • Visuospatial memory
    • Working memory
    • Attention
    • Executive functions 2
  • The severity of cognitive impairment correlates with the cumulative benzodiazepine dose 2
  • These cognitive effects occur even in the absence of neurological or psychiatric comorbidities (except anxiety or depression) 2

Risks Beyond Cognitive Effects

  • Benzodiazepines are associated with additional adverse effects that may impact quality of life:
    • Increased risk of falls and fractures 3
    • Risk of dependence and withdrawal 4, 5
    • Reduced mobility and decline of functional independence 3
    • Unsafe driving skills 3
    • Potential for addiction 3

Prescribing Patterns and Concerns

  • Despite guidelines recommending only short-term use, nearly 30% of young users are prescribed benzodiazepines for longer than 6 months 6
  • The prevalence of benzodiazepine dispensation among individuals aged 0-24 years increased by 22% between 2006 and 2013, with a 20% rise specifically in young adults 6
  • 65% of benzodiazepine prescriptions for young people are initiated outside of psychiatric services, suggesting potential inappropriate prescribing 6

Recommendations for Use in Young Adults

  • Current consensus guidelines advise use of benzodiazepines solely on a short-term basis 3
  • The American Geriatrics Society Beers Criteria identifies benzodiazepines as high-risk medications due to their cognitive effects, though these guidelines are primarily focused on older adults 3
  • For anxiety disorders in young people, non-benzodiazepine alternatives should be considered first-line, including:
    • Cognitive-behavioral therapy
    • Problem-solving therapy
    • Supportive psychotherapy
    • Antidepressants when pharmacotherapy is needed 3

Mitigation Strategies if Benzodiazepines Must Be Used

  • Use the lowest effective dose for the shortest duration possible 3
  • Avoid concurrent use with other CNS depressants and alcohol 3
  • Monitor for cognitive effects, particularly with tasks requiring attention and memory 1
  • Consider gradual tapering when discontinuing to minimize withdrawal effects 3, 5
  • Educate patients about potential cognitive effects and risks 1

In conclusion, the evidence clearly indicates that benzodiazepines can cause cognitive deficits in 18-year-olds, particularly with prolonged or high-dose use. Healthcare providers should carefully weigh these risks against potential benefits and consider non-pharmacological or alternative pharmacological approaches when treating anxiety or sleep disorders in young adults.

References

Research

The effects of benzodiazepines on cognition.

The Journal of clinical psychiatry, 2005

Research

Multifocal cognitive dysfunction in high-dose benzodiazepine users: a cross-sectional study.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2017

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.